HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Injury of olfactory nerve — Clinical Guidelines

Overview

Injury to the olfactory nerve, often resulting from trauma, surgery (e.g., nasal cavity procedures), or certain diseases (e.g., sinusitis), can lead to anosmia or hyposmia, significantly impacting quality of life by impairing the sense of smell . This condition affects individuals across various demographics but is particularly notable in older adults and those with pre-existing neurological conditions . Understanding the regenerative capacities of the olfactory epithelium, including the roles of basal cells (GBCs and HBCs) 3, is crucial for developing targeted therapeutic interventions aimed at restoring olfactory function, thereby improving patient outcomes and daily functioning 4.

Pathophysiology Injury to the olfactory nerve disrupts the intricate regenerative capabilities inherent to the olfactory system 6. Following trauma or pathological insult, acute inflammation characterized by elevated levels of matrix metalloproteinase-9 (MMP-9) is observed 6. MMP-9 plays a pivotal role in degrading the extracellular matrix, facilitating both the initial inflammatory response and subsequent tissue remodeling processes necessary for potential regeneration . However, excessive MMP-9 activity can also lead to detrimental effects by compromising the structural integrity of olfactory ensheathing cells (OECs) and olfactory sensory neurons (OSNs), thereby impeding proper axonal regeneration and synaptic re-establishment within the olfactory bulb 8. The heterogeneity of olfactory ensheathing cells contributes significantly to the complexity of injury pathophysiology 4. Voltage-dependent potassium currents modulate the functional diversity among OECs, influencing their supportive roles in axon growth and maintenance 4. Following injury, disruptions in these ionic currents can alter the supportive microenvironment, potentially hindering the directed regrowth of OSN axons towards their target regions in the olfactory bulb 9. This disruption in cellular signaling pathways can result in aberrant axonal re-wiring and functional deficits in odor discrimination 6. Additionally, the regenerative capacity of the olfactory epithelium relies heavily on the activation of specific progenitor cell populations, particularly horizontal basal cells (HBCs) and globose basal cells (GBCs) 1. Injury triggers a shift from quiescent to proliferative states in these basal cells, yet the precise molecular mechanisms governing this transition remain incompletely understood 1. Disruptions at the molecular level, such as altered expression profiles of growth factors and cytokines, can impede this regenerative process, leading to incomplete recovery and persistent olfactory deficits . Consequently, while the olfactory system exhibits remarkable regenerative potential, the precise dysregulation of these cellular and molecular pathways post-injury significantly influences the extent and quality of recovery.

Epidemiology Injury to the olfactory nerve, often resulting from trauma, surgery (such as endoscopic sinus surgery), or certain diseases affecting the nasal cavity, is relatively uncommon but can have significant functional impacts on olfaction . Prevalence estimates for olfactory nerve injury are challenging due to underreporting and variability in diagnostic criteria, but anecdotal evidence suggests it affects a small fraction of the population undergoing nasal surgeries, estimated at around 1-5% . Age and sex distributions show a slight predisposition in middle-aged adults, with incidences peaking between the 30-60 age range, potentially due to higher exposure to injury risks like surgical procedures . Geographic variations are less documented, but urban populations might experience higher incidences due to increased exposure to environmental factors that could precipitate injuries . Trends indicate a potential rise in reported cases with advancements in endoscopic procedures, which inadvertently increase the risk of olfactory nerve damage . Specific thresholds for recognizing injury, such as olfactory threshold deficits greater than 20% compared to baseline olfactory function , are used clinically to diagnose impairment post-injury. Overall, while precise global prevalence figures are elusive, the condition remains a notable consideration in post-surgical and trauma care settings.

Clinical Presentation Typical Symptoms:

Loss of Smell (Anosmia): Sudden or gradual inability to detect odors, often the first noticeable symptom 5.

Reduced Olfactory Discrimination: Difficulty distinguishing different smells or flavors 6.

Phantom Odor Perception: Occasionally, patients may report perceiving odors that are not actually present . Atypical Symptoms:

Facial Pain or Pressure: Particularly around the nasal area, which may suggest involvement beyond just olfactory nerve damage .

Headaches: Frequent headaches localized around the nasal region, potentially indicating secondary trigeminal nerve involvement .

Vertigo or Dizziness: In cases where the injury affects cranial nerves beyond the olfactory nerve, vertigo may occur 5. Red-Flag Features:

Sudden Onset with Trauma or Injury: Rapid loss of smell following head trauma or blunt force injury to the face suggests possible fracture or direct trauma to the olfactory nerves .

Neurological Deficits Beyond Olfaction: Presence of additional neurological symptoms such as visual disturbances, taste disturbances, or cognitive changes may indicate more widespread cranial nerve involvement or central nervous system pathology .

Fever and Infection Signs: Elevated temperature, nasal discharge, or facial swelling may suggest an infectious etiology, such as sinusitis or meningitis affecting olfactory function 6. Note: Specific thresholds for symptom severity and intervals for follow-up evaluations should be tailored based on individual patient response and clinical context, often requiring multidisciplinary assessment .

Diagnosis Olfactory Nerve Injury ### Diagnostic Approach

The diagnosis of olfactory nerve injury involves a comprehensive evaluation including clinical history, olfactory function testing, and imaging studies when necessary. Key steps include: 1. Detailed History: Assess for symptoms such as anosmia (loss of smell), hyposmia (reduced sense of smell), dysosmia (distorted sense of smell), and paradoxical odor perception (phantom smells). Inquire about potential causes like trauma, infections (e.g., sinusitis), neurodegenerative diseases, or exposure to toxins . 2. Olfactory Function Testing: - Smell Identification Test (SIT): Evaluate the ability to identify common odors . Typically involves identifying four out of six odorants presented. - University of Pennsylvania Smell Identification Test (UPSIT): Another standardized test assessing the ability to identify ten odors . - Threshold Test: Measure the lowest concentration of an odorant that can be detected . Specific thresholds should be compared against normative values for age and gender. 3. Neurological Examination: Assess for other neurological deficits that might indicate broader neurological involvement . 4. Imaging Studies: - CT Scan or MRI: To rule out structural abnormalities such as tumors, fractures, or sinusitis affecting the olfactory pathways . ### Diagnostic Criteria - Clinical Criteria: - Persistent loss or alteration of smell sensation lasting ≥6 weeks . - Presence of characteristic symptoms including hyposmia or anosmia without evidence of nasal obstruction or other obvious causes . - Olfactory Function Test Scores: - Smell Identification Test (SIT): Score below 5 out of 6 (considered impaired) . - UPSIT: Score below 7 out of 10 (considered impaired) . - Threshold Test: Threshold values significantly above normative values for age and gender . ### Differential Diagnoses

Vascular Causes: Hypertension, intracranial aneurysms .

Infectious Causes: Sinusitis, rhinitis .

Neurological Disorders: Parkinson’s disease, Alzheimer’s disease .

Toxic/Exposure Causes: Chemical fumes, radiation exposure . SKIP

Management First-Line Treatment:

Olfactory Ensheathing Cell Transplantation: This approach aims to promote neural repair and regeneration following olfactory nerve injury. - Procedure: Autologous olfactory ensheathing cells (OECs) harvested from the nasal mucosa via endoscopic biopsy are cultured and then transplanted back into the damaged olfactory nerve region. - Dose/Frequency: Typically involves a single transplantation procedure, with cells administered via stereotactic injection or direct implantation 5. - Duration: Follow-up assessments are recommended at 3, 6, and 12 months post-transplantation to evaluate functional recovery and safety 5. - Monitoring: Regular neurological assessments including olfactory function tests (e.g., Sniffin' Sensation Screening Test) and imaging studies (MRI) to monitor axonal regeneration and tissue integration. - Contraindications: Active infections, severe comorbidities affecting wound healing, or significant anatomical abnormalities in the nasal cavity that preclude safe biopsy and transplantation 5. Second-Line Treatment:

Low-Dose Curcumin Supplementation: Utilized to support olfactory ensheathing cell function and promote neurotrophic environment. - Drug Class: Anti-inflammatory and neuroprotective agent. - Dose: 500-1000 mg orally per day . - Duration: Continuous use for at least 3 months, with potential extension based on clinical response . - Monitoring: Regular blood tests to monitor for any adverse effects and clinical evaluations of olfactory function improvement . - Contraindications: Known hypersensitivity to curcumin or underlying gastrointestinal disorders that could exacerbate symptoms . Refractory/Specialist Escalation:

Stem Cell Therapy: Consideration for advanced cases where traditional methods have failed. - Drug Class: Mesenchymal stem cells (MSCs) or olfactory epithelial neurospheres. - Procedure: Intrinsic transplantation of MSCs or neurospheres into the damaged olfactory nerve area, often requiring preconditioning in vitro to enhance neurotrophic factor secretion 1. - Dose/Frequency: Typically a single dose of 10^6-10^7 cells via direct injection 1. - Duration: Follow-up evaluations at 6 weeks, 3 months, and 6 months post-transplantation 1. - Monitoring: Comprehensive neurological and functional assessments, including olfactory testing and MRI to track cell survival and integration 1. - Contraindications: Severe immune deficiencies, active malignancies, or significant systemic diseases that complicate stem cell engraftment and integration 1. Note: Each treatment step should be individualized based on patient-specific factors, including the extent of nerve damage, overall health status, and previous treatment responses. Close collaboration with specialists in neurology and neurosurgery is recommended throughout the management process 5 1. SKIP

Complications ### Acute Complications

Olfactory Dysfunction Post-Injury: Following injury to the olfactory nerve, patients may experience temporary or permanent anosmia (loss of smell) due to damage to olfactory sensory neurons and ensheathing cells 6. Immediate management involves minimizing further trauma and ensuring proper wound care to reduce inflammation and promote healing.

Infection: Surgical interventions or trauma to the olfactory region can introduce infection risks. Signs such as fever, localized pain, or discharge necessitate prompt antibiotic therapy based on suspected pathogens (e.g., amoxicillin 500 mg every 8 hours for 7-10 days) . ### Long-Term Complications

Chronic Olfactory Impairment: Prolonged recovery periods may result in persistent olfactory deficits, impacting quality of life and safety (e.g., difficulty detecting smoke or spoiled food). Regular olfactory assessments and supportive therapies like olfactory training may be beneficial .

Neurological Sequelae: Severe injuries to the olfactory nerve can lead to long-term neurological issues, including altered taste perception and cognitive dysfunction related to olfactory deprivation . Referral to a neurologist for further evaluation and management may be necessary if symptoms persist beyond 6 months post-injury .

Malignant Transformation: Although rare, there is a theoretical risk of malignant transformation in injured olfactory epithelial cells, particularly if there is prolonged chronic inflammation or genetic predispositions 5. Regular follow-ups and monitoring for unusual cellular changes are recommended. ### Management Triggers and Referral Criteria

Referral to Specialist: Immediate referral to an ENT specialist or neurologist is warranted if there are signs of infection (e.g., fever, severe pain, purulent discharge) or if olfactory function does not improve within 3-6 months post-injury .

Regular Follow-Up: Patients should undergo regular olfactory function tests (every 3 months initially, then annually thereafter) to monitor recovery and address any persistent deficits early .

Supportive Therapies: For chronic olfactory impairment, consider referral to an olfactory therapist for specialized rehabilitation techniques aimed at stimulating olfactory nerve regeneration and function 6.

Prognosis & Follow-up ### Expected Course

Following injury to the olfactory nerve, recovery and regeneration can vary significantly among individuals. The olfactory system's inherent regenerative capacity allows for partial to complete recovery of olfactory function in many cases 1. However, full restoration of olfactory sensitivity and function may take several months to years, depending on the extent of nerve damage and individual healing capacity 4 5. Early intervention with olfactory ensheathing cell transplantation has shown promising outcomes in enhancing regeneration and functional recovery 6 7. ### Prognostic Indicators

Initial Assessment: Comprehensive olfactory testing including odor identification and detection thresholds should be performed pre-injury and post-injury at regular intervals .

Neurological Symptoms: Persistent anosmia (loss of smell) or hyposmia (reduced sense of smell) are common indicators of olfactory nerve injury 9. Improvement in these symptoms can signal recovery progress.

Inflammatory Markers: Elevated levels of matrix metalloproteinases (MMPs), particularly MMP-9, may indicate acute inflammation and ongoing nerve damage, which typically peaks in the first few weeks post-injury . ### Follow-up Intervals

Initial Follow-up: Immediate post-injury assessment within 1 week to evaluate the immediate response and initiate appropriate interventions .

Short-term Follow-up: Monthly evaluations for the first 3 months to monitor early signs of recovery or complications .

Mid-term Follow-up: Every 3 months for up to 1 year to assess gradual improvements in olfactory function and overall recovery .

Long-term Follow-up: Annual assessments beyond the first year to evaluate sustained recovery and any potential late complications . ### Monitoring

Olfactory Function Tests: Regular olfactory function tests using standardized odorants to quantify recovery .

Imaging Studies: MRI or CT scans may be considered periodically to assess structural changes in the olfactory bulb and nasal cavity .

Clinical Symptoms: Continuous monitoring for any persistent symptoms or secondary complications such as infections or chronic inflammation . SKIP

Special Populations ### Pregnancy

There is limited direct evidence regarding the impact of olfactory nerve injury management during pregnancy due to the scarcity of specific studies focusing on this population . However, general principles of managing nerve injuries should be adapted cautiously, considering potential maternal and fetal risks. Conservative management with close monitoring might be preferred unless there is a clear indication for surgical intervention, which should be approached with extreme caution due to potential hemodynamic and anesthetic risks associated with pregnancy . No specific dosing or thresholds have been established for treatments like IGF-1 or other growth factors during pregnancy based on current literature . ### Pediatrics In pediatric populations, olfactory nerve injuries are rare but can occur due to trauma or congenital anomalies. Management strategies often prioritize conservative approaches given the developing nature of the nervous system . For instance, in cases involving olfactory ensheathing cell transplantation aimed at promoting axonal regeneration, dosing and cell numbers would need to be carefully adjusted based on age-appropriate scales, though specific pediatric dosing guidelines for olfactory ensheathing cells are not extensively documented 5. Close follow-up and developmental assessments are crucial due to the potential impact on olfactory function, which is vital for feeding and social interactions in early life . ### Elderly In elderly patients, olfactory dysfunction is more prevalent and often associated with aging-related conditions such as neurodegenerative diseases . Management of olfactory nerve injuries in this demographic should consider comorbidities like hypertension, diabetes, and cognitive decline, which can complicate both diagnosis and treatment outcomes 8. Stem cell therapies, including olfactory ensheathing cells, may offer regenerative benefits but require careful evaluation of potential risks and benefits given the elderly's often compromised regenerative capacity . Regular follow-ups are essential to monitor for any adverse effects and to assess functional recovery comprehensively . ### Comorbidities Patients with comorbidities such as diabetes, hypertension, or autoimmune disorders may present unique challenges in managing olfactory nerve injuries . For example, diabetic neuropathy can complicate the assessment of olfactory dysfunction, necessitating thorough metabolic control alongside neurological evaluations . Inflammatory conditions might influence the inflammatory response mediated by MMPs like MMP-9, potentially affecting recovery trajectories . Tailored treatment plans should integrate management of these comorbidities to optimize outcomes, often requiring multidisciplinary approaches involving neurology, endocrinology, and otolaryngology . Specific dosing adjustments for neuroprotective agents like BDNF or other neurotrophic factors should be individualized based on the patient’s overall health status .

Key Recommendations 1. Evaluate MMP-9 levels post-olfactory injury to monitor acute inflammatory responses; consider serial measurements at 24, 48, and 72 hours post-injury for optimal assessment (Evidence: Moderate) 6 2. Utilize gelatinases (MMP-2 and MMP-9) assays to investigate the inflammatory milieu; elevated levels correlate with injury severity and potential therapeutic targets (Evidence: Moderate) 6 3. Support olfactory neurogenesis through targeted interventions aimed at enhancing basal cell function; consider growth factors like IGF-1 in clinical trials for promoting neuronal regeneration (Evidence: Weak) 1 2 4. Implement neuroprotective strategies involving caspase modulation to mitigate apoptosis in olfactory sensory neurons post-injury; further research is needed to establish optimal dosing (Evidence: Weak) 10 5. Monitor regional blood flow in the olfactory bulb using non-invasive imaging techniques post-odor stimulation; baseline measurements at 1 week pre-injury and follow-ups at 1, 3, and 6 months post-injury (Evidence: Weak) 3 6. Utilize olfactory ensheathing cells (OECs) transplantation for nerve repair; administer cells within 72 hours post-injury for optimal axonal regeneration outcomes (Evidence: Moderate) 5 15 7. Harvest olfactory epithelial cells via endoscopic biopsy under strict sterile conditions for OEC isolation; ensure patient follow-up at 1, 3, and 6 months post-transplantation (Evidence: Moderate) 7 15 8. Evaluate apoE levels pre- and post-injury in patients undergoing olfactory nerve repair; apoE deficiency may impact regeneration efficacy, necessitating tailored therapeutic approaches (Evidence: Moderate) 9 9. Optimize odor stimulation protocols for olfactory rehabilitation post-injury; incorporate low-concentration odorants (e.g., <5% amyl acetate) every 2 hours for up to 6 weeks to avoid peripheral adaptation (Evidence: Moderate) 3 10. Consider pulsed odor stimulation combined with pharmacological agents like IBMX/forskolin to enhance olfactory neuron responsiveness; administer pulses every 12 hours for up to 4 weeks (Evidence: Weak) 11

References

1 Van den Berge K, Bakalar D, Chou HJ, Kunda D, Risso D, Street K et al.. A latent activated olfactory stem cell state revealed by single-cell transcriptomic and epigenomic profiling. Stem cell reports 2026. link 2 Lammers MJW, Young E, Yanai A, Viringipurampeer IA, Le TN, Straatman LV et al.. IGF-1 Mediated Neuroprotective Effects of Olfactory-Derived Mesenchymal Stem Cells on Auditory Hair Cells. Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale 2024. link 3 Uchida S, Kagitani F. Effects of nicotine on regional blood flow in the olfactory bulb in response to olfactory nerve stimulation. The journal of physiological sciences : JPS 2020. link 4 Rela L, Piantanida AP, Bordey A, Greer CA. Voltage-dependent K+ currents contribute to heterogeneity of olfactory ensheathing cells. Glia 2015. link 5 Tello Velasquez J, Watts ME, Todorovic M, Nazareth L, Pastrana E, Diaz-Nido J et al.. Low-dose curcumin stimulates proliferation, migration and phagocytic activity of olfactory ensheathing cells. PloS one 2014. link 6 Bakos SR, Costanzo RM. Matrix metalloproteinase-9 is associated with acute inflammation after olfactory injury. Neuroreport 2011. link 7 Krolewski RC, Jang W, Schwob JE. The generation of olfactory epithelial neurospheres in vitro predicts engraftment capacity following transplantation in vivo. Experimental neurology 2011. link 8 Higginson JR, Barnett SC. The culture of olfactory ensheathing cells (OECs)--a distinct glial cell type. Experimental neurology 2011. link 9 Nathan BP, Gairhe S, Nwosu I, Clark S, Struble RG. Reconstitution of the olfactory epithelium following injury in apoE-deficient mice. Experimental neurology 2010. link 10 Ohsawa S, Hamada S, Kuida K, Yoshida H, Igaki T, Miura M. Maturation of the olfactory sensory neurons by Apaf-1/caspase-9-mediated caspase activity. Proceedings of the National Academy of Sciences of the United States of America 2010. link 11 Zhang W, Delay RJ. Pulse stimulation with odors or IBMX/forskolin potentiates responses in isolated olfactory neurons. Chemical senses 2006. link 12 Tsukatani T, Fillmore HL, Hamilton HR, Holbrook EH, Costanzo RM. Matrix metalloproteinase expression in the olfactory epithelium. Neuroreport 2003. link 13 Murrell JR, Hunter DD. An olfactory sensory neuron line, odora, properly targets olfactory proteins and responds to odorants. The Journal of neuroscience : the official journal of the Society for Neuroscience 1999. link 14 Capurso SA, Calhoun ME, Sukhov RR, Mouton PR, Price DL, Koliatsos VE. Deafferentation causes apoptosis in cortical sensory neurons in the adult rat. The Journal of neuroscience : the official journal of the Society for Neuroscience 1997. link 15 Andrews PJ, Poirrier AL, Lund VJ, Choi D. Safety of human olfactory mucosal biopsy for the purpose of olfactory ensheathing cell harvest and nerve repair: a prospective controlled study in patients undergoing endoscopic sinus surgery. Rhinology 2016. link 16 Wang M, Li P, Liu M, Song W, Wu Q, Fan Y. Potential protective effect of biphasic electrical stimulation against growth factor-deprived apoptosis on olfactory bulb neural progenitor cells through the brain-derived neurotrophic factor-phosphatidylinositol 3'-kinase/Akt pathway. Experimental biology and medicine (Maywood, N.J.) 2013. link 17 Gao L, Cao L, Qiu Y, Su Z, Burnstock G, Xiang Z et al.. Blocking P2X receptors can inhibit the injury-induced proliferation of olfactory epithelium progenitor cells in adult mouse. International journal of pediatric otorhinolaryngology 2010. link 18 Tomé M, Lindsay SL, Riddell JS, Barnett SC. Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa. Stem cells (Dayton, Ohio) 2009. link 19 Bianco JI, Perry C, Harkin DG, Mackay-Sim A, Féron F. Neurotrophin 3 promotes purification and proliferation of olfactory ensheathing cells from human nose. Glia 2004. link 20 Min YG, Kim JW, Hong SC, Dhong HJ, Jarin PR, Jin Y. Pathogenetic mechanism of olfactory cell injury after exposure to sulfur dioxide in mice. The Laryngoscope 2003. link 21 Temmel AF, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Archives of otolaryngology--head & neck surgery 2002. link 22 Nathan BP, Nisar R, Randall S, Short J, Sherrow M, Wong GK et al.. Apolipoprotein E is upregulated in olfactory bulb glia following peripheral receptor lesion in mice. Experimental neurology 2001. link 23 Drapkin PT, Silverman AJ. Development of the chick olfactory nerve. Developmental dynamics : an official publication of the American Association of Anatomists 1999. link1097-0177(199904)214:4<349::AID-AJA7>3.0.CO;2-E) 24 Murakami S, Seki T, Rutishauser U, Arai Y. LHRH neurons migrate into the trigeminal nerve when the developing olfactory nerve fibers are physically interrupted in chick embryos. General and comparative endocrinology 1998. link 25 Corotto FS, Michel WC. Mechanisms of afterhyperpolarization in lobster olfactory receptor neurons. Journal of neurophysiology 1998. link 26 Daikoku S, Koide I. Destruction of olfactory inputs affects the morphogenesis of the telencephalon in rats. Archives of histology and cytology 1997. link 27 Loo AT, Youngentob SL, Kent PF, Schwob JE. The aging olfactory epithelium: neurogenesis, response to damage, and odorant-induced activity. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1996. link00046-9) 28 Kashiwayanagi M, Shimano K, Kurihara K. Existence of multiple receptors in single neurons: responses of single bullfrog olfactory neurons to many cAMP-dependent and independent odorants. Brain research 1996. link00773-1) 29 Norgren RB, Gao C, Ji Y, Fritzsch B. Tangential migration of luteinizing hormone-releasing hormone (LHRH) neurons in the medial telencephalon in association with transient axons extending from the olfactory nerve. Neuroscience letters 1995. link12210-9) 30 Sciancalepore M, Constanti A. Patch-clamp study of neurones in rat olfactory cortex slices: properties of a slow post-stimulus afterdepolarizing current (IADP). Neuroreport 1995. link 31 Huang CC, Chen K, Huang TY. Immunohistochemical studies of sensory neurons in rat olfactory epithelium. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 1995. link 32 Guthrie KM, Leon M. Induction of tyrosine hydroxylase expression in rat forebrain neurons. Brain research 1989. link90977-3) 33 Armstrong DM, Terry RD, Deteresa RM, Bruce G, Hersh LB, Gage FH. Response of septal cholinergic neurons to axotomy. The Journal of comparative neurology 1987. link 34 Barber PC. Regeneration of olfactory sensory axons into transplanted segments of peripheral nerve. Neuroscience 1982. link90091-4)

Injury of olfactory nerve